Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group

NEXT STORY
BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual Meeting
PREV STORY
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UroGen Pharma Expands Clinical Development Leadership Team

Mark Schoenberg, M.D., Named Chief Medical Officer Elyse Seltzer, M.D., Appointed Senior Vice President ...

author_avatar
NASDAQ Market News

The global pet oral care products market is expected to reach US$ 2,270.33 million by 2028 from US$ 1,465.07 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028

author_avatar
NASDAQ Market News

Onconova Announces Successful End-of-Phase 2 Meeting with FDA for Oral Rigosertib and Azacitidine Combination

NEWTOWN, Pa., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

author_avatar
NASDAQ Market News